 | |
- close
- close
|
PR Newswire
Oct 22
Comment
CHICAGO, Oct. 22 /PRNewswire-FirstCall/ -- Deerfield Capital Corp. (NYSE AMEX: DFR) (the "Company") today announced that the Company will report third quarter financial results on Monday, November 9, 2009 after the market closes. About the Company
StreetInsider.com
Sep 28
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Insulet+%28PODD%29+Amends+Deerfield+Credit+Facility%3B+Issues+2.855M+Shares/4973339.html for the full story.
PR Newswire
Aug 10
Comment
CHICAGO, Aug. 10 /PRNewswire-FirstCall/ -- Deerfield Capital Corp. (NYSE AMEX: DFR) ("DFR" or the "Company") today announced the results of operations for its second quarter ended June 30, 2009. Second Quarter 2009 Summary -- Net income attributable
Insurance Journal
Jul 30
Comment
The owner of the property where a New Hampshire man was murdered is at odds with his insurance company over a wrongful death lawsuit from the man's family.
Michael Connors owned the Deerfield ...
Insurance Journal
Jul 24
Comment
Greg Waltz has joined Mack Insurance Group, Inc. and become one of the three partners in the Deerfield Beach, Florida-based company.
The company plans to change its name to Mack, Mack and ...
Bloomberg
Jul 16
Comment
(Update1) Baxter International Inc., the
biggest maker of treatments for blood disorders, said second-
quarter profit rose 8 percent, beating analyst estimates. The
company raised its earnings forecast for the full year.
MarketWatch
Jul 16
Comment
Baxter International Inc. said Thursday second-quarter net income grew by 8% to $587 million, or 96 cents a share, from $544 million, or 85 cents a share in the year-ago period, despite lower revenue from the Deerfield, Ill. medical products...
FierceBiotech
Jun 17
Comment
There's still money to be had. Arena Pharmaceuticals has gained a commitment of $100 million in funding from healthcare investors Deerfield Management. In exchange, the biotech will issue Deerfield 28 million shares of common stock at $5.42 per...
FierceBiotech
May 20
Comment
Deerfield Management has agreed to provide an additional $40 million to Array BioPharma to fund its drug development work and add some fresh confidence as the developer pursues new partnership deals. That money is in addition to the $80 million...
Bloomberg
May 15
Comment
(Update1) Baxter International Inc.’s blood
thinner heparin didn’t cause deaths at a Delaware hospital,
according to the company’s investigation.
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
DFR AT A GLANCE
References
| ||||||
|
|
